Treatment of Hereditary Angioedema Prodrome with Recombinant C1-esterase Inhibitor (Ruconest)

计划入组 5 人 · 首次发布于 2024 年 11 月 15 日

Recombinant Human C1 Esterase Inhibitor in the Prevention of Contrast-induced Nephropathy in High-risk Subjects

计划入组 80 人 · 首次发布于 2016 年 8 月 16 日

Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Recombinant Human C1 Esterase Inhibitor in Healthy Adult Subjects

计划入组 48 人 · 首次发布于 2016 年 1 月 26 日

Recombinant complement C1-esterase inhibitor protein (CSL Limited)

Conestat alfa(Ruconest)

C1-esterase inhibitor

Pharming Group

Netherlands

Corvus Pharmaceuticals

United States

Kura Oncology

United States

Pharming Group to Present 12 Studies on Rare Disease Treatments at 2025 ACAAI Meeting

European Patent Board Revokes C1-Esterase Inhibitor Patent for Kidney Transplant Rejection Treatment

Dyadic Secures Japanese Patent for C1 Recombinant Protein Platform, Accelerates Asia-Pacific Expansion